MoneyWorks4Me

Astal Laboratories - Quaterly Results

27 Jan 2025 Evaluate
The Turnover for the quarter ended December 2024 of Rs. 144.59 millions increase by 71.89% from Rs. 84.12 millions.The Net Profit of the company reported a remarkable increase of 410.88% to Rs. 24.88  millions  from Rs. 4.87 millions in previous same quarter.The company reported a good operating profit of 33.79 millions compared to 4.95 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 144.59 84.12 71.89 407.65 220.23 85.10 236.48 34.28 589.85
Other Income 0.56 0.00 0.00 0.90 0.12 650.00 0.13 1.79 -92.74
PBIDT 33.79 4.95 582.63 86.83 10.88 698.07 11.17 0.40 2692.50
Interest 2.81 0.00 0.00 4.35 0.00 0.00 0.00 0.00 0.00
PBDT 30.98 4.95 525.86 82.48 10.88 658.09 11.17 0.40 2692.50
Depreciation 0.81 0.08 912.50 1.19 0.30 296.67 0.30 0.08 275.00
PBT 30.17 4.87 519.51 81.29 10.58 668.34 10.87 0.32 3296.88
TAX 5.29 0.00 0.00 19.48 0.00 0.00 3.02 0.16 1787.50
Deferred Tax 0.97 0.00 0.00 1.22 0.00 0.00 0.08 0.06 33.33
PAT 24.88 4.87 410.88 61.81 10.58 484.22 7.85 0.16 4806.25
Equity 98.46 49.40 99.31 98.46 98.46 0.00 98.46 39.90 146.77
PBIDTM(%) 23.37 5.88 297.14 21.30 4.94 331.15 4.72 1.17 304.78
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..